Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Oliver Cornely"'
Autor:
Johanna Kessel, Anna-Catharina Rossaert, Tilman Lingscheid, Jan Grothe, Thomas Harrer, Christoph Wyen, Daniela Tominski, T. Bollinger, Anna Katharina Kehr, Sven Kalbitz, Christian Hoffmann, Oliver Cornely, Uwe Koppe, Christoph Stephan, Volker Rickerts
Publikováno v:
International Journal of Medical Microbiology, Vol 314, Iss , Pp 151614- (2024)
Cryptococcosis is the most prevalent fungal infection of the central nervous system worldwide. We performed a retrospective multicenter cohort study to gain insights into the epidemiology of cryptococcosis in Germany. We describe the use of diagnosti
Externí odkaz:
https://doaj.org/article/097729a7e29a4d86b7042f6511016ed8
Autor:
Clemens Warnke, Stephanie Stock, Martin Hellmich, Gereon R Fink, Heidrun Golla, Raymond Voltz, Judith Haas, Julia Strupp, Volker Limmroth, Anne Müller, Eckhard Bonmann, Kim Dillen, Thomas Dojan, Solveig Ungeheuer, Petra Schmalz, Angelika Staß, Vanessa Mildenberger, Yasemin Goereci, Veronika Dunkl, Oliver Cornely, Alexander Stahmann, Peter Löcherbach, Lothar Burghaus, Kathrin Gerbershagen, Gereon Nelles, Thomas Joist, Herbert Temmes
Publikováno v:
BMJ Open, Vol 12, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/aeb5d20b31af45b9a736d4b1e4a29421
Autor:
Stefanie Wunsch, Christoph Zurl, Heimo Strohmaier, Andreas Meinitzer, Jasmin Rabensteiner, Wilfried Posch, Cornelia Lass-Flörl, Oliver Cornely, Gudrun Pregartner, Elisabeth König, Gebhard Feierl, Martin Hoenigl, Juergen Prattes, Ines Zollner-Schwetz, Thomas Valentin, Robert Krause
Publikováno v:
Journal of Fungi, Vol 7, Iss 2, p 101 (2021)
Interleukin (IL) 17A plays a decisive role in anti-Candida host defense. Previous data demonstrated significantly increased IL-17A values in candidemic patients. We evaluated levels and time courses of IL-17A, and other cytokines suggested to be invo
Externí odkaz:
https://doaj.org/article/f0d2f2112c6d49699164756b1fde5467
Autor:
Sebastian Wille, Pauline Schumacher, Jenny Paas, Dirk Tenholte, Okyaz Eminaga, Ute Müller, Noemi Muthen, Jan Mehner, Oliver Cornely, Udo Engelmann
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e96280 (2014)
AimsLong-term urodynamics are required because bladder-emptying disorders are often not clearly revealed by conventional urodynamics. Patients with severe clinical overactive bladder symptoms, for instance, often show normal results. This may be due
Externí odkaz:
https://doaj.org/article/27c33243f1be4caa87ecb11f474af1cb
Autor:
Bernd Kupfer, Jörg Vehreschild, Oliver Cornely, Rolf Kaiser, Gerhard Plum, Sergei Viazov, Caspar Franzen, Ramona-Liza Tillmann, Arne Simon, Andreas Müller, Oliver Schildgen
Publikováno v:
Emerging Infectious Diseases, Vol 12, Iss 10, Pp 1614-1616 (2006)
Externí odkaz:
https://doaj.org/article/49038b84ea5a47e49c3fc0bd8e44340c
Autor:
Laşin Özbek, Umur Topçu, Mehtap Manay, Buğra Han Esen, Sevval Nur Bektas, Serhat Aydın, Barış Özdemir, Sofya N. Khostelidi, Nikolai Klimko, Oliver Cornely, Johnny Zakhour, Souha S. Kanj, Danila Seidel, Martin Hoenigl, Önder Ergönül
Publikováno v:
Clinical Microbiology and Infection. 29:722-731
Autor:
Oliver Cornely, Sibylle Mellinghoff
Publikováno v:
Blood. 140:2655-2657
Publikováno v:
The Journal of antimicrobial chemotherapy. 77(12)
Objectives Enrolment of subjects to clinical trials investigating novel drugs for infectious diseases is an ongoing challenge. In this study, we evaluate factors associated with non-enrolment in treatment trials for invasive candidiasis. Methods We c
Autor:
Francesco Marchesi, Jon Salmanton-Garcia, Ziad EMARAH, Klára PIUKOVICS, Marcio Nucci, Alberto Lopez-Garcia, Zdenek Racil, Francesca Farina, Marina POPOVA, Sofia ZOMPI, Ernesta Audisio, Marie-Pierre Ledoux, Luisa VERGA, Barbora Weinbergerova, Tomas Szotkowski, Maria Silva, Nicola Stefano Fracchiolla, Nick DE JONGE, Graham Collins, Monia Marchetti, Gabriele MAGLIANO, Carolina GARCÍA-VIDAL, Monika M. BIERNAT, Jaap van Doesum, Marina MACHADO, Fatih Demirkan, Murtadha Al Khabori, Pavel Zak, Benjamin Visek, Igor STOMA, Gustavo-Adolfo MÉNDEZ, Johan Maertens, Nina KHANNA, Ildefonso Espigado, Giulia DRAGONETTI, Luana Fianchi, Maria Ilaria Del Principe, Alba CABIRTA, Irati ORMAZABAL-VÉLEZ, Ozren Jaksic, Caterina BUQUICCHIO, Valentina BONUOMO, Josip Batinić, Ali S. OMRANI, Sylvain Lamure, Olimpia Finizio, Noemí FERNÁNDEZ, Iker FALCES-ROMERO, Ola BLENNOW, Rui BERGANTIM, Natasha Ali, Sein WIN, Jens VAN PRAET, Maria Chiara Tisi, Ayten SHIRINOVA, Martin SCHÖNLEIN, Juergen PRATTES, Monica PIEDIMONTE, Verena Petzer, Milan NAVRÁTIL, Austin Kulasekararaj, Pavel Jindra, null Jiří, Andreas Glenthøj, Rita FAZZI, Cristina de Ramón, Chiara Cattaneo, Maria CALBACHO, Nathan C. BAHR, Shaimaa Saber EL-ASHWL, Raúl Córdoba, Michaela HANAKOVA, Giovanni ZAMBROTTA, Mariarita Sciumè, Stephen Booth, Raquel NUNES-RODRIGUES, Maria Vittoria SACCHI, Nicole GARCÍA-POUTÓN, Juan-Alberto MARTÍN-GONZÁLEZ, Sofya KHOSTELIDI, Stefanie GRÄFE, Laman RAHIMLI, alessandro busca, Paolo Corradini, Martin HOENIGL, Nikolai KLIMKO, Philipp Koehler, Antonio PAGLIUCA, Francesco Passamonti, Oliver Cornely, Livio pagano
Patients with acute myeloid leukemia (AML) are at high risk of mortality from coronavirus disease 2019 (COVID-19). The optimal management of AML patients with COVID-19 has not been established. Our multicenter study included 388 adult AML patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18db6307d75572e30f484fa3abcd35cb
https://doi.org/10.21203/rs.3.rs-1323457/v1
https://doi.org/10.21203/rs.3.rs-1323457/v1
Publikováno v:
Medical Mycology.